GLP-1 plotters use published pharmacokinetic data from clinical trials and FDA documentation
Importantly, their influence extends to skeletal muscle, where GLP-1 RAs promote glucose uptake via the AMP-activated protein kinase pathway, increase vascular blood flow, and mitigate glucotoxicity, thereby supporting muscle protein synthesis and inhibiting catabolic pathways [14, 15]
It is classified as a triple hormone receptor agonist, which means it activates three separate hormone pathways in the body at the same time
Retatrutide has completed Phase 3 trials with data published
Absence seizures are more common in children
A systematic review in Addictive Behaviors found that 15 to 20% of patients stopping long-term SSRI therapy experience clinically significant discontinuation effects